DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Mamounas EP, Bandos H, Lembersky BC. et al.
Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor+ breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI).
San Antonio Breast Cancer Symposium 2019;
2019: GS4-01
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.